Eukaryotic Transcription Inhibitors
What is Natural Selection?
Antibiotic Selection
Structural Isomerism
Types of Selection
Antibody Structure
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 14, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
Tahereh Damghani1, Shenghan Song2, Kaly S Lin1
1Department of Chemistry, College of Arts and Sciences, The State University of New York at Buffalo, Buffalo, New York 14260, United States.
Fourth-generation EGFR inhibitors, BI-8128 and BI-4732, show promise against non-small cell lung cancer with T790M and C797S mutations. BI-8128 exhibits enhanced binding to double mutations, addressing EGFR inhibitor drug resistance.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: